Compare Indonesia Energy Corporation Limited (INDO) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Energy Corporation Limited vs TransMedics Group Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.74 (market cap $43.24M), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 63.4× Indonesia Energy Corporation Limited's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Indonesia Energy Corporation Limited nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and TransMedics Group Inc for 24 Days on average.
| INDO | TMDX | |
|---|---|---|
Market Cap | $43.24M | $2.74B |
Volume | 116,953 | 949,331 |
Sector | Energy | Health |
52-Week High | $6.74 | $150.42 |
52-Week Low | $2.49 | $61.99 |
Typical Hold Time | 24 Days | 24 Days |
Enterprise Value | $38.18M | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INDO trades at $2.74, down 1.08% on the day, with a bearish technical signal from moving averages. The company reported a net loss of $5.10 million on $2.01 million revenue in 2025, with negative profit margins and cash flow from operations. Recent news highlights progress on the K-29 well drilling and upcoming investor presentations.
Despite a 100% buy rating from 3 analysts, INDO faces significant financial challenges with persistent losses and negative cash flow. The stock's outlook hinges on successful production from new wells, but execution risks and weak fundamentals present substantial downside potential for investors.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
